Personalized prediction of lifetime benefits with statin therapy for asymptomatic individuals: a modeling study.

BACKGROUND: Physicians need to inform asymptomatic individuals about personalized outcomes of statin therapy for primary prevention of cardiovascular disease (CVD). However, current prediction models focus on short-term outcomes and ignore the competing risk of death due to other causes. We aimed to...

Full description

Bibliographic Details
Main Authors: Bart S Ferket, Bob J H van Kempen, Jan Heeringa, Sandra Spronk, Kirsten E Fleischmann, Rogier L G Nijhuis, Albert Hofman, Ewout W Steyerberg, M G Myriam Hunink
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC3531501?pdf=render